Lipid nanoparticle portfolio for enabling non-viral delivery - Cytiva

Physicochemical profiles of ionizable lipids will depend on application, therefore analytical evaluation is essential to validating the LNP potency and performance at each stage of drug development depending on the TPP (Target Product Profile).
Cytiva offers a Genomic Medicine Toolkit to enable access to NxGen microfluidic technologies, a novel well characterized lipid library, and scientific expertise in formulation and process development to design and optimize vehicles for nucleic acid therapeutics, thereby providing an end-to-end solution enabling future transformative genomic medicines.
Learn more at www.cytiva.com